New research from the University of Liverpool has identified the role of a specific protein in the human body that can help prevent the survival and spread of eye cancer, by initiating cancer ‘cell-suicide’.
The new findings may help revolutionise the approach to metastatic uveal melanoma (UM) – a cancer that arises from the pigment cells (melanocytes) in the eye, and for which there is currently no effective treatment.
Metastasis is the spread of a cancer or other disease from one organ or part of the body to another without being directly connected with it. This occurs in about half of the patients with UM.
Although rare, UM is the most common primary eye cancer in adults. While the primary tumour can often be treated very effectively, up to 50% of patients develop metastases most often in the liver, for whom no effective therapy is available.
Programmed cell death
Apoptosis, or programmed cell death, is a rapid and irreversible process to efficiently eliminate dysfunctional cells. A hallmark of cancer is the ability of malignant cells to evade apoptosis.
Dr Luminita Paraoan, from the University’s Department of Eye and Vision Science in the Institute of Ageing and Chronic Disease, has published new findings in the British Journal of Cancer that identify the requirement of a protein called p63 for the initiation of apoptosis in UM.
Chromosome 3 is one of the 23 pairs of chromosomes in humans. People normally have two copies of each chromosome. One part of chromosome 3 contains the gene for the protein p63. Unfortunately people with aggressive (resistant to apoptosis) UM do not have this part and therefore do not have the p63 protein.
Dr Paraoan’s research found that if the p63 gene is used in combination with another gene, called p53, they can effectively target UM and start the process of apoptosis in the cancerous cells.
Tumour suppressor genes
The p53 gene is from a class of genes called tumour suppressors which are mutated in cases of cancer. Tumour suppressor genes are protective genes. Normally, they limit cell growth by monitoring how quickly cells divide into new cells, repairing damaged DNA, and controlling when a cell dies.
When a tumour suppressor gene is mutated, for example in cancer cases, cells grow uncontrollably and may eventually form a mass called a tumour. Therefore p53 itself is ineffective in starting the process of apoptosis of cancer calls in UM.
Of her research Dr Luminita said: “The study highlights for the first time the requirement of p63 in the initiation of apoptosis in UM”.
“Our findings have broad-ranging implications for other cancers in which apoptosis is evaded or is problematic. They will hopefully prove advantageous in designing therapeutic approaches to cancerous tumours that are currently resistant to chemotherapy and radiotherapy.”
Receive an email update when we add a new CANCER TREATMENT article.
The Latest on: Eye cancer treatment
via Google News
The Latest on: Eye cancer treatment
- Dynamic duo: AI teamed with radiologist diagnoses breast cancer with 90% accuracyon October 18, 2019 at 11:43 am
New York University scientists, teamed with artificial intelligence, have been able to accurately diagnose breast cancer at a 90% clip, speeding up treatment and hopefully reducing the need for ...
- ‘Pretty in Pink’: Grandparents Raising Grandchildren spread breast cancer awarenesson October 17, 2019 at 7:18 am
everywhere the eye looked, the color pink could be found. Dr. Kim, from Sierra View Medical Center, spoke to the women about breast cancer and current treatments. Dr. Kim wants to convey the message ...
- Biotech Stock On The Radar: Assessing Mirati's Oncology Franchise With An Eye On Multiple Readoutson October 16, 2019 at 5:11 pm
Founded in 1995, San Diego, California-based Mirati pursues a novel approach to cancer treatment by targeting genetic changes in tumor cells that lead to uncontrolled tumor growth and spreading. Its ...
- The Disappointing Reality of Crowdfunding Cancer Careon October 16, 2019 at 4:09 am
What resulted was an “eye-opening snapshot” of patients’ financial situations ... “Patients aren’t achieving their goal in this new-age safety net,” he said. “The financial burden of cancer treatment ...
- Intraocular Melanoma Treatment Market Business Opportunities and Future Scope Till 2026on October 15, 2019 at 12:06 am
It is typically characterized with blurred vision or a dark spot on the iris. It begins in the middle of three layers of the wall of the eye. According to the National Cancer Institute (NCI), the ...
- I Spent 10 Years Keeping My Breast Cancer a Secret from My Sonon October 14, 2019 at 5:35 pm
But we always kept our eye on the prize: We wanted to have kids ... I found out in January that the cancer wasn’t growing, so they wanted to watch and wait four months. Through radiation treatment I ...
- Researchers discover a new way to improve the assessment of prostate cancer aggressivenesson October 14, 2019 at 6:29 am
termed 'radiomic features," which have the potential to uncover disease characteristics that fail to be seen by the naked eye. This technique could complement traditional assessment methods and may ...
- Volunteer group My Happy Haven creates special place for cancer survivorson October 13, 2019 at 7:00 am
Businesses that have donated money, supplies or time include Central Park Dentistry, Iowa Bariatrics, North Iowa Credit Union, Hearing Associates, North Iowa Eye Clinic PC, Christianson Interiors ...
- Keep an eye out for companies thinking pinkon October 13, 2019 at 1:05 am
Evelyn H. Lauder (Estée’s daughter-in-law) co-created the iconic pink ribbon, the symbol for breast cancer awareness in 1992. Unfortunately, just as many brands exploit the cause for sales. That’s why ...
via Bing News